Another Study Highlights Link Between Digoxin and Death Risk
A new study finds that the heart drug digoxin can significantly increase the risk of death among heart patients, especially those suffering from atrial fibrillation.
Tag Archives: Digoxin Overdose
-
-
Digoxin Side Effects May Increase Risk of Death When Used With Xarelto: Study
Another study finds links between digoxin and an increased risk of death among atrial fibrillation patients.
-
Digoxin Side Effects May Increase Risk of Death: Study
Researchers from Stanford warn that despite commonly being used to treat patients with atrial fibrillation, the heart drug digoxin appears to increase their risk of death.
-
Digitek Settlement Reached to Resolve Lawsuits Over Recalled Heart Drug
A settlement has been reached that will resolve all outstanding state and federal Digitek lawsuits, according to federal court records.
-
Digitek Litigation Stayed Until October by MDL Judge
A federal judge has issued a temporary stay of the Digitek litigation pending in the MDL, halting all proceedings for 75 days in lawsuits filed on behalf of individuals who…
-
Digitek Trial in Federal MDL Scheduled to Begin January 2011
A federal judge presiding over the consolidated Digitek litigation, which is centralized in the U.S. District Court for the Southern District of West Virginia, has scheduled the first trial over…
-
Federal and State Judges to Hold Joint Hearing in Digitek Recall Lawsuits
The judges presiding over hundreds of Digitek recall lawsuits in federal court and various states will hold a joint hearing next year to review the scientific evidence in the cases,…
-
Digitek Lawsuits Selected for First Trials in Federal MDL
Five Digitek overdose lawsuits have been selected to serve as “bellwether” cases that will lead the way for hundreds of cases filed against Actavis Totowa and distributors of their generic…
-
Generic Digoxin Recall Issued Due to Oversized Tablets
Caraco Pharmaceutical Laboratories has issued a generic digoxin recall after discovering that some pills may have been distributed that contain more or less of the active drug than they should.…
